Jeff Yass’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
Jeff Yass's KYMR Position: Q3 2026 in Review
Jeff Yass increased its Kymera Therapeutics (KYMR) stake by 146% in Q3 2026, buying an estimated $846K and bringing the position to 12,447 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #7170.
Jeff Yass first reported a position in KYMR in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.51M in Q2 2025. 301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Jeff Yass held 12,447 shares of Kymera Therapeutics worth $1.39M as of Q3 2026.
- Jeff Yass bought 7,386 Kymera Therapeutics shares in Q3 2026, an estimated $846K.
- Kymera Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7170 holding.
- Jeff Yass first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 22 quarters since.
- Jeff Yass's Kymera Therapeutics position peaked at $2.51M in Q2 2025.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.